928
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of cGAS aggravated the host inflammatory response to Aspergillus fumigatus

, , &
Pages 86-100 | Received 08 Jan 2023, Accepted 02 May 2023, Published online: 16 May 2023

References

  • Margalit A, Kavanagh K. The innate immune response to Aspergillus fumigatus at the alveolar surface. FEMS Microbiol Rev. 2015;39(5):670–687. doi:10.1093/femsre/fuv018.
  • Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2019;200(5):535–550. doi:10.1164/rccm.201906-1185ST.PMC6727169.
  • Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149–e162. doi:10.1016/S1473-3099(20)30847-1.PMC7833078.
  • Verweij PE, Zhang J, Debets AJM, et al. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management. Lancet Infect Dis. 2016;16(11):e251–e260. doi:10.1016/S1473-3099(16)30138-4.
  • Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24 Suppl 1(Suppl 1):e1–e38. doi:10.1016/j.cmi.2018.01.002.
  • van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latge JP. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15(11):661–674. doi:10.1038/nrmicro.2017.90.
  • Lehrnbecher T, Kalkum M, Champer J, Tramsen L, Schmidt S, Klingebiel T. Immunotherapy in invasive fungal infection–focus on invasive aspergillosis. Curr Pharm Des. 2013;19(20):3689–3712. doi:10.2174/1381612811319200010.
  • Latge JP, Chamilos G. Aspergillus fumigatus and Aspergillosis in 2019. Clin Microbiol Rev. 2019;33(1):e00140-18. doi:10.1128/CMR.00140-18.PMC6860006.
  • Barros B, Almeida BR, Barros DTL, Toledo MS, Suzuki E. Respiratory epithelial cells: more than just a physical barrier to fungal infections. JoF. 2022;8(6):548. doi:10.3390/jof8060548.PMC9225092.
  • Leiva-Juarez MM, Kolls JK, Evans SE. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol. 2018;11(1):21–34. doi:10.1038/mi.2017.71.PMC5738267.
  • Dambuza IM, Levitz SM, Netea MG, Brown GD. Fungal recognition and Microbiol Spectr. 2017;5(4). doi:10.1128/microbiolspec.FUNK-0050-2016. PMID: 28752813
  • Croft CA, Culibrk L, Moore MM, Tebbutt SJ. Interactions of Aspergillus fumigatus Conidia with airway epithelial cells: a critical review. Front Microbiol. 2016;7:472. doi:10.3389/fmicb.2016.00472.PMC4823921.
  • Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019;363(6431):eaat8657. doi:10.1126/science.aat8657.
  • Cheng Z, Dai T, He X, et al. The interactions between cGAS-STING pathway and pathogens. Signal Transduct Target Ther. 2020;5(1):91. doi:10.1038/s41392-020-0198-7.PMC7293265.
  • McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103. doi:10.1038/nri3787.PMC7162685.
  • Liu N, Pang X, Zhang H, Ji P. The cGAS-STING pathway in bacterial infection and bacterial immunity. Front Immunol. 2021;12:814709. doi:10.3389/fimmu.2021.814709.PMC8793285.
  • Ni G, Ma Z, Damania B. cGAS and STING: at the intersection of DNA and RNA virus-sensing networks. PLoS Pathog. 2018;14(8):e1007148. doi:10.1371/journal.ppat.1007148.PMC6095619.
  • Rivera A, Hohl TM, Collins N, et al. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med. 2011;208(2):369–381. doi:10.1084/jem.20100906.PMC3039849.
  • Mikawa K, Nishina K, Takao Y, Obara H. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg. 2003;97(6):1751–1755. doi:10.1213/01.ANE.0000086896.90343.13.
  • Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017;17(11):e357–e366. doi:10.1016/s1473-3099(17)30309-2.
  • Desoubeaux G, Cray C. Rodent models of invasive aspergillosis due to Aspergillus fumigatus: still a long path toward standardization. Front Microbiol. 2017;8:841. doi:10.3389/fmicb.2017.00841.PMC5432554.
  • Salazar F, Brown GD. Antifungal innate immunity: a perspective from the last 10 years. J Innate Immun. 2018;10(5–6):373–397. doi:10.1159/000488539.PMC6784043.
  • Pekmezovic M, Dietschmann A, Gresnigt MS. Type I interferons during host-fungus interactions: is antifungal immunity going viral? PLoS Pathog. 2022;18(8):e1010740. doi:10.1371/journal.ppat.1010740.PMC9409562.
  • Kotenko SV, Rivera A, Parker D, Durbin JE. Type III IFNs: beyond antiviral protection. Semin Immunol. 2019;43:101303. doi:10.1016/j.smim.2019.101303.PMC7141597.
  • Espinosa V, Dutta O, McElrath C, et al. Type III interferon is a critical regulator of innate antifungal immunity. Sci Immunol. 2017;2(16):eaan5357. doi:10.1126/sciimmunol.aan5357.PMC5880030.
  • Broggi A, Granucci F, Zanoni I. Type III interferons: balancing tissue tolerance and resistance to pathogen invasion. J Exp Med. 2020;217(1):e20190295. doi:10.1084/jem.20190295.PMC7037241.
  • Beisswenger C, Hess C, Bals R. Aspergillus fumigatus conidia induce interferon-beta signalling in respiratory epithelial cells. Eur Respir J. 2012;39(2):411–418. doi:10.1183/09031936.00096110.
  • Homma T, Kato A, Bhushan B, et al. Role of Aspergillus fumigatus in triggering protease-activated receptor-2 in airway epithelial cells and skewing the cells toward a T-helper 2 bias. Am J Respir Cell Mol Biol. 2016;54(1):60–70. doi:10.1165/rcmb.2015-0062OC.PMC4742929.
  • Seyedmousavi S, Davis MJ, Sugui JA, et al. Exogenous stimulation of type I interferon protects mice with chronic granulomatous disease from Aspergillosis through early recruitment of host-protective neutrophils into the lung. mBio. 2018;9(2):9. doi:10.1128/mBio.00422-18.PMC5874922.
  • Biondo C, Signorino G, Costa A, et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur J Immunol. 2011;41(7):1969–1979. doi:10.1002/eji.201141490.
  • Majer O, Bourgeois C, Zwolanek F, et al. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog. 2012;8(7):e1002811. doi:10.1371/journal.ppat.1002811.PMC3406095.
  • Biondo C, Midiri A, Gambuzza M, et al. IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J Immunol. 2008;181(1):566–573. doi:10.4049/jimmunol.181.1.566.
  • Inglis DO, Berkes CA, Hocking Murray DR, Sil A. Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect Immun. 2010;78(9):3871–3882. doi:10.1128/IAI.00204-10.PMC2937464.
  • Tan X, Sun L, Chen J, Chen ZJ. Detection of microbial infections through innate immune sensing of nucleic acids. Annu Rev Microbiol. 2018;72:447–478. doi:10.1146/annurev-micro-102215-095605.
  • Schoggins JW, MacDuff DA, Imanaka N, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. 2014;505(7485):691–695. doi:10.1038/nature12862.PMC4077721.
  • Gow NA, Netea MG. Medical mycology and fungal immunology: new research perspectives addressing a major world health challenge. Phil Trans R Soc B. 2016;371(1709):20150462. doi:10.1098/rstb.2015.0462.PMC5095541.
  • Wang X, Caffrey-Carr AK, Liu KW, et al. MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against Aspergillus fumigatus. J Immunol. 2020;205(11):3058–3070. doi:10.4049/jimmunol.2000802.PMC7785165.
  • Carvalho A, De Luca A, Bozza S, et al. TLR3 essentially promotes protective class I-restricted memory CD8(+) T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood. 2012;119(4):967–977. doi:10.1182/blood-2011-06-362582.
  • Rubino I, Coste A, Le Roy D, et al. Species-specific recognition of Aspergillus fumigatus by toll-like receptor 1 and toll-like receptor 6. J Infect Dis. 2012;205(6):944–954. doi:10.1093/infdis/jir882.
  • Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe. 2011;9(5):415–424. doi:10.1016/j.chom.2011.04.007.PMC3100664.
  • Wang X, Cunha C, Grau MS, et al. MAVS expression in alveolar macrophages is essential for host resistance against Aspergillus fumigatus. J Immunol. 2022;209(2):346–353. doi:10.4049/jimmunol.2100759.PMC9307106.
  • Dutta O, Espinosa V, Wang K, Avina S, Rivera A. Dectin-1 promotes type I and III interferon expression to support optimal antifungal immunity in the lung. Front Cell Infect Microbiol. 2020;10:321. doi:10.3389/fcimb.2020.00321.PMC7360811.